Healthcare Professionals - EpiPen

Skip to primary navigation
Skip to content

Scroll down or Click Here for
Important Safety Information

About EpiPen Auto-Injector
How To Use EpiPen
Allergic Emergencies Are You at Risk?
Create A Plan
My EpiPen
Healthcare Professionals

Patient Information (PDF)
Prescribing Information (PDF)

Healthcare Professionals

What is Anaphylaxis?
Identifying At‑Risk Patients
Management of Anaphylaxis
About EpiPen^® (epinephrine) Auto-Injector
Frequently Asked Questions
Full Prescribing Information
Practice Tools
Information for Pharmacists

Indications

EpiPen^® and EpiPen Jr Auto-Injectors (0.3 and 0.15 mg epinephrine) are indicated in the emergency treatment of type 1 allergic reactions, including anaphylaxis, to allergens, idiopathic and exercise-induced anaphylaxis, and in patients with a history or increased risk of anaphylactic reactions. Selection of the appropriate dosage strength is determined according to body weight.

Important Safety Information

EpiPen Auto-Injectors should only be injected into the anterolateral aspect of the thigh. DO NOT INJECT INTO BUTTOCK, OR INTRAVENOUSLY.

Epinephrine should be used with caution in patients with certain heart diseases, and in patients who are on drugs that may sensitize the heart to arrhythmias, because it may precipitate or aggravate angina pectoris and produce ventricular arrhythmias. Arrhythmias, including fatal ventricular fibrillation, have been reported in patients with underlying cardiac disease or taking cardiac glycosides or diuretics. Patients with certain medical conditions or who take certain medications for allergies, depression, thyroid disorders, diabetes, and hypertension, may be at greater risk for adverse reactions. Other adverse reactions include transient moderate anxiety, apprehensiveness, restlessness, tremor, weakness, dizziness, sweating, palpitations, pallor, nausea and vomiting, headache, and/or respiratory difficulties.

EpiPen and EpiPen Jr Auto-Injectors are intended for immediate self-administration as emergency supportive therapy only and are not intended as a substitute for immediate medical or hospital care.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

For additional information please contact us at 800-395-3376.

©2011 Dey Pharma, L.P. All rights reserved.
DEY® and the Dey logo are registered trademarks of Dey Pharma, L.P.
EpiPen®, EpiPen 2-Pak®, and EpiPen Jr 2-Pak® are registered trademarks of Mylan Inc. licensed exclusively to its wholly-owned subsidiary, Dey Pharma, L.P.
MyEpiPen™ is a trademark of Dey Pharma, L.P.

Privacy Statement
Copyright and Legal Disclaimer
Contact Us
Sitemap